XML 16 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
License revenue $ 0 $ 0 $ 7,500,000 $ 0
Operating expenses:        
Research and development 24,069,000 16,653,000 66,657,000 50,581,000
General and administrative 14,453,000 11,351,000 52,546,000 30,989,000
Total operating expenses 38,522,000 28,004,000 119,203,000 81,570,000
Operating loss (38,522,000) (28,004,000) (111,703,000) (81,570,000)
Other income, net 160,000 235,000 572,000 1,695,000
Net loss (38,362,000) (27,769,000) (111,131,000) (79,875,000)
Other comprehensive income (loss):        
Net unrealized (loss)/gain on marketable securities (55,000) (20,000) (139,000) 120,000
Foreign currency translation adjustment (51,000) 13,000 (123,000) 0
Comprehensive loss $ (38,468,000) $ (27,776,000) $ (111,393,000) $ (79,755,000)
Net loss per share — basic (in USD per share) $ (0.39) $ (0.31) $ (1.13) $ (0.99)
Net loss per share — diluted (in USD per share) $ (0.39) $ (0.31) $ (1.13) $ (0.99)
Weighted-average common shares used to compute net loss per share - basic (in shares) 98,126 88,867 97,966 80,995
Weighted-average common shares used to compute net loss per share - diluted (in shares) 98,126 88,867 97,966 80,995